Square wave voltammetric determination of the angiotensin-converting enzyme inhibitors cilazapril, quinapril and ramipril in pharmaceutical formulations
- 31 May 2003
- journal article
- Published by Elsevier BV in Il Farmaco
- Vol. 58 (5), 343-350
- https://doi.org/10.1016/s0014-827x(03)00043-0
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Overview of the angiotensin-converting-enzyme inhibitorsAmerican Journal of Health-System Pharmacy, 2000
- Factors to consider in selecting an angiotensin-converting-enzyme inhibitorAmerican Journal of Health-System Pharmacy, 2000
- Spectrophotometric Determination of Enalapril Maleate and Ramipril in Dosage FormsSpectroscopy Letters, 2000
- Determination of active ingredients in the pharmaceutical formulations containing hydrochlorothiazide and its binary mixtures with benazepril hydrochloride, triamterene and cilazapril by ratio spectra derivative spectrophotometry and vierordt’s methodJournal of Pharmaceutical and Biomedical Analysis, 1999
- Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?The Lancet, 1998
- From kinetics to dynamics: are there differences between ACE inhibitors?European Heart Journal, 1997
- Simultaneous Determination of Cilazapril and Hydrochlorothiazide in Tablets by Spectrophotometric MethodsAnalytical Letters, 1996
- QuinaprilDrugs, 1994
- CilazaprilDrugs, 1991
- RamiprilDrugs, 1990